{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:28:30Z","timestamp":1793953710947,"version":"4.8.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["akdh.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1053\/j.akdh.2026.02.001","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:33:34Z","timestamp":1782182014000},"page":"71-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Collagen Genes\u2013Related Glomerular Disease"],"prefix":"10.1053","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5966-4096","authenticated-orcid":false,"given":"Grainne","family":"Butler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2746-6903","authenticated-orcid":false,"given":"Cathy","family":"Quinlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2494-3970","authenticated-orcid":false,"given":"Michelle N.","family":"Rheault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3454","key":"10.1053\/j.akdh.2026.02.001_bib1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/bmj.1.3454.504","article-title":"Hereditary familial congenital haemorrhagic nephritis","volume":"1","author":"Alport","year":"1927","journal-title":"Br Med J"},{"key":"10.1053\/j.akdh.2026.02.001_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/B978-0-12-363706-2.50008-8","article-title":"Structure and biosynthesis of basement membranes","volume":"6","author":"Kefalides","year":"1973","journal-title":"Int Rev Connect Tissue Res"},{"issue":"10","key":"10.1053\/j.akdh.2026.02.001_bib3","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1097\/01.ASN.0000141462.00630.76","article-title":"The molecular basis of Goodpasture and Alport syndromes: beacons for the discovery of the collagen IV family","volume":"15","author":"Hudson","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2026.02.001_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1432-1033.1981.tb05690.x","article-title":"A network model for the organization of type IV collagen molecules in basement membranes","volume":"120","author":"Timpl","year":"1981","journal-title":"Eur J Biochem"},{"key":"10.1053\/j.akdh.2026.02.001_bib5","first-page":"1","article-title":"Structure, development, and molecular pathology of basement membranes","volume":"29","author":"Timpl","year":"1986","journal-title":"Int Rev Exp Pathol"},{"issue":"6","key":"10.1053\/j.akdh.2026.02.001_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF00283147","article-title":"Alteration in the distribution of type IV collagen in glomerular basal laminae in diabetic rats as revealed by immunocytochemistry and morphometrical approach","volume":"28","author":"Bendayan","year":"1985","journal-title":"Diabetologia"},{"issue":"15","key":"10.1053\/j.akdh.2026.02.001_bib7","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1074\/jbc.273.15.8767","article-title":"Glomerular basement membrane. Identification of a novel disulfide-cross-linked network of alpha3, alpha4, and alpha5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome","volume":"273","author":"Gunwar","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1053\/j.akdh.2026.02.001_bib8","series-title":"Chapter 4 - Type IV Collagen. Biochemistry of Collagens, Laminins and Elastin (Third Edition)","first-page":"37","author":"Sand","year":"2024"},{"issue":"10","key":"10.1053\/j.akdh.2026.02.001_bib9","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1172\/JCI119431","article-title":"Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis","volume":"99","author":"Kalluri","year":"1997","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1053\/j.akdh.2026.02.001_bib10","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","article-title":"Alport syndrome: a unified classification of genetic disorders of collagen IV \u03b1345: a position paper of the Alport Syndrome Classification Working Group","volume":"93","author":"Kashtan","year":"2018","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2026.02.001_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100631","article-title":"Alport syndrome: clinical spectrum and therapeutic advances","volume":"5","author":"Gregorio","year":"2023","journal-title":"Kidney Med"},{"issue":"3","key":"10.1053\/j.akdh.2026.02.001_bib12","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1523-1755.2000.00250.x","article-title":"Estimating prevalence in single-gene kidney diseases progressing to renal failure","volume":"58","author":"Levy","year":"2000","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.akdh.2026.02.001_bib13","first-page":"1241","article-title":"X-linked inheritance of Alport syndrome: family P revisited","volume":"35","author":"Hasstedt","year":"1983","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.akdh.2026.02.001_bib14","series-title":"Alport syndrome. Diseases of the Kidney","first-page":"617","author":"Atkin","year":"1988"},{"issue":"6","key":"10.1053\/j.akdh.2026.02.001_bib15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jmoldx.2012.06.005","article-title":"Skin biopsy is a practical approach for the clinical diagnosis and molecular genetic analysis of X-linked Alport\u2019s syndrome","volume":"14","author":"Wang","year":"2012","journal-title":"J Mol Diagn"},{"issue":"9","key":"10.1053\/j.akdh.2026.02.001_bib16","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1681\/ASN.2020071065","article-title":"Prevalence estimates of predicted pathogenic COL4A3-COL4A5 variants in a population sequencing database and their implications for Alport Syndrome","volume":"32","author":"Gibson","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2026.02.001_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.xkme.2020.12.007","article-title":"Type IV collagen variants in CKD: performance of computational predictions for identifying pathogenic variants","volume":"3","author":"Shulman","year":"2021","journal-title":"Kidney Med"},{"issue":"6","key":"10.1053\/j.akdh.2026.02.001_bib18","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1681\/ASN.0000000580","article-title":"Genotype-first analysis in an unselected health system-based population and phenotypic severity of COL4A5 variants","volume":"36","author":"Zellers","year":"2025","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2026.02.001_bib19","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00467-019-04282-y","article-title":"Variations of type IV collagen-encoding genes in patients with histological diagnosis of focal segmental glomerulosclerosis","volume":"35","author":"Demir","year":"2020","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"10.1053\/j.akdh.2026.02.001_bib20","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1007\/s00467-008-0918-7","article-title":"A big boy with proteinuria. Focal and segmental glomerulosclerosis","volume":"23","author":"Quinlan","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"10.1053\/j.akdh.2026.02.001_bib21","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/ckj\/sfad193","article-title":"Genetic testing in focal segmental glomerulosclerosis: in whom and when?","volume":"16","author":"Tato","year":"2023","journal-title":"Clin Kidney J"},{"issue":"6","key":"10.1053\/j.akdh.2026.02.001_bib22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2021.04.017","article-title":"Pathogenic variants in the genes affected in Alport syndrome (COL4A3-COL4A5) and their association with other kidney conditions: a review","volume":"78","author":"Savige","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.akdh.2026.02.001_bib23","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.ekir.2022.06.001","article-title":"Heterozygous pathogenic COL4A3 and COL4A4 variants (autosomal dominant Alport syndrome) are common, and not typically associated with end-stage kidney failure, hearing loss, or ocular abnormalities","volume":"7","author":"Savige","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1053\/j.akdh.2026.02.001_bib24","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.ekir.2018.08.002","article-title":"Should we diagnose autosomal dominant Alport Syndrome when there Is a pathogenic heterozygous COL4A3 or COL4A4 variant?","volume":"3","author":"Savige","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"11","key":"10.1053\/j.akdh.2026.02.001_bib25","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.2215\/CJN.03120322","article-title":"Digenic Alport syndrome","volume":"17","author":"Savige","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.akdh.2026.02.001_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jmedgenet-2014-102822","article-title":"Evidence of digenic inheritance in Alport syndrome","volume":"52","author":"Mencarelli","year":"2015","journal-title":"J Med Genet"},{"issue":"7","key":"10.1053\/j.akdh.2026.02.001_bib29","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2215\/CJN.19171220","article-title":"Genetic basis of type IV collagen disorders of the kidney","volume":"16","author":"Quinlan","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2026.02.001_bib30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","article-title":"X-Linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males","volume":"11","author":"Jais","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2026.02.001_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161802","article-title":"X-linked and autosomal recessive Alport syndrome: pathogenic variant features and further genotype-phenotype correlations","volume":"11","author":"Savige","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1053\/j.akdh.2026.02.001_bib32","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1681\/ASN.2009070784","article-title":"Genotype-phenotype correlation in X-linked Alport syndrome","volume":"21","author":"Bekheirnia","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2026.02.001_bib33","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.kint.2020.06.038","article-title":"Genotype-phenotype correlations influence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome","volume":"98","author":"Yamamura","year":"2020","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2026.02.001_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-011-1836-7","article-title":"Women and Alport syndrome","volume":"27","author":"Rheault","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2026.02.001_bib35","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","article-title":"X-Linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study","volume":"14","author":"Jais","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2026.02.001_bib36","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/ndt\/gfp551","article-title":"X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome","volume":"25","author":"Rheault","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.akdh.2026.02.001_bib37","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ekir.2017.04.011","article-title":"Natural history and genotype-phenotype correlation in female X-linked Alport syndrome","volume":"2","author":"Yamamura","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1053\/j.akdh.2026.02.001_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.580376","article-title":"X-Linked Alport syndrome in women: genotype and clinical course in 24 cases","volume":"7","author":"Mastrangelo","year":"2020","journal-title":"Front Med"},{"issue":"5","key":"10.1053\/j.akdh.2026.02.001_bib39","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/ndt\/gfn779","article-title":"Women with Alport syndrome: risks and rewards of kidney donation","volume":"24","author":"Kashtan","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.akdh.2026.02.001_bib40","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/ndt\/gfn635","article-title":"Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome","volume":"24","author":"Gross","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.akdh.2026.02.001_bib41","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.ajkd.2021.02.326","article-title":"Clinical and genetic features of autosomal dominant Alport syndrome: a cohort study","volume":"78","author":"Furlano","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.akdh.2026.02.001_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-06525-9","article-title":"Genotype\u2013phenotype correlations for COL4A3\u2013COL4A5 variants resulting in Gly substitutions in Alport syndrome","volume":"12","author":"Gibson","year":"2022","journal-title":"Sci Rep"},{"issue":"12","key":"10.1053\/j.akdh.2026.02.001_bib43","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1681\/ASN.2012100985","article-title":"COL4A3\/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome","volume":"24","author":"Storey","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2026.02.001_bib44","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/jcm8020178","article-title":"Features of autosomal recessive Alport syndrome: a systematic review","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med"},{"issue":"11","key":"10.1053\/j.akdh.2026.02.001_bib45","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1007\/s00467-023-05993-z","article-title":"COL4A gene variants are common in children with hematuria and a family history of kidney disease","volume":"38","author":"Rheault","year":"2023","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2026.02.001_bib47","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00467-024-06538-8","article-title":"Detection of Alport gene variants in children and young people with persistent haematuria","volume":"40","author":"Ng","year":"2025","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2026.02.001_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2024.101329","article-title":"Payer Perspectives on Genomic Testing in the United States: a systematic literature review","volume":"27","author":"Wiedower","year":"2024","journal-title":"Genet Med"},{"issue":"5","key":"10.1053\/j.akdh.2026.02.001_bib49","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/cge.14006","article-title":"Out-of-pocket and private pay in clinical genetic testing: a scoping review","volume":"100","author":"Grant","year":"2021","journal-title":"Clin Genet"},{"issue":"4","key":"10.1053\/j.akdh.2026.02.001_bib50","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.ajkd.2004.12.023","article-title":"Microscopic hematuria in pregnancy: relevance to pregnancy outcome","volume":"45","author":"Brown","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.akdh.2026.02.001_bib51","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jama.2011.1141","article-title":"Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease","volume":"306","author":"Vivante","year":"2011","journal-title":"JAMA"},{"issue":"5, Part 1","key":"10.1053\/j.akdh.2026.02.001_bib52","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3476(79)80710-6","article-title":"Microscopic hematuria in schoolchildren: epidemiology and clinicopathologic evaluation","volume":"95","author":"Vehaskari","year":"1979","journal-title":"J Pediatr"},{"issue":"8","key":"10.1053\/j.akdh.2026.02.001_bib53","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.paed.2012.02.011","article-title":"Haematuria and proteinuria in childhood","volume":"22","author":"Lunn","year":"2012","journal-title":"Paediatr Child Health"},{"issue":"10","key":"10.1053\/j.akdh.2026.02.001_bib55","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.ekir.2023.07.010","article-title":"The phenotypic spectrum of COL4A3 heterozygotes","volume":"8","author":"Solanki","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1053\/j.akdh.2026.02.001_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49271-2","article-title":"Prediction of chronic kidney disease progression using recurrent neural network and electronic health records","volume":"13","author":"Zhu","year":"2023","journal-title":"Sci Rep"},{"issue":"7767","key":"10.1053\/j.akdh.2026.02.001_bib57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-019-1390-1","article-title":"A clinically applicable approach to continuous prediction of future acute kidney injury","volume":"572","author":"Toma\u0161ev","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1053\/j.akdh.2026.02.001_bib58","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41431-023-01532-4","article-title":"Reanalysis of genomic data, how do we do it now and what if we automate it? A qualitative study","volume":"32","author":"Fehlberg","year":"2024","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"10.1053\/j.akdh.2026.02.001_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41431-024-01633-8","article-title":"Reanalysis of genomic data in rare disease: current practice and attitudes among Australian clinical and laboratory genetics services","volume":"32","author":"Best","year":"2024","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1053\/j.akdh.2026.02.001_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2022.10.001","article-title":"Incidental molecular diagnoses and heterozygous risk alleles in a carrier screening cohort","volume":"25","author":"Reiner","year":"2023","journal-title":"Genet Med"},{"issue":"5","key":"10.1053\/j.akdh.2026.02.001_bib61","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"10.1053\/j.akdh.2026.02.001_bib62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13073-016-0391-z","article-title":"ClinGen Pathogenicity Calculator: a configurable system for assessing pathogenicity of genetic variants","volume":"9","author":"Patel","year":"2017","journal-title":"Genome Med"},{"issue":"4","key":"10.1053\/j.akdh.2026.02.001_bib64","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.akdh.2026.02.001_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/8620557","article-title":"Evaluating the utility of REVEL and CADD for interpreting variants in amyotrophic lateral sclerosis genes","volume":"2023","author":"Fiorini","year":"2023","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1053\/j.akdh.2026.02.001_bib66","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1038\/s41467-023-43878-9","article-title":"Polygenic risk alters the penetrance of monogenic kidney disease","volume":"14","author":"Khan","year":"2023","journal-title":"Nat Commun"},{"issue":"5","key":"10.1053\/j.akdh.2026.02.001_bib67","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1681\/ASN.0000000000000094","article-title":"Clinical and genetic characteristics of CKD patients with high-risk APOL1 genotypes","volume":"34","author":"Elliott","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"5 Suppl 1","key":"10.1053\/j.akdh.2026.02.001_bib68","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.ajkd.2018.06.021","article-title":"Kidney disease among African Americans: a population perspective","volume":"72","author":"Laster","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1053\/j.akdh.2026.02.001_bib69","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1681\/ASN.2019030218","article-title":"Genome-wide association study of diabetic kidney disease highlights biology involved in glomerular basement membrane collagen","volume":"30","author":"Salem","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2026.02.001_bib70","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/ndt\/gfae031","article-title":"Increased prevalence of kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants","volume":"39","author":"Furlano","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.akdh.2026.02.001_bib71","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/ndt\/gfae002","article-title":"Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome","volume":"39","author":"Bada-Bosch","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1053\/j.akdh.2026.02.001_bib72","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/ndt\/gfae290","article-title":"Challenging the narrative of Alport syndrome spectrum: no link with cystic phenotype","volume":"40","author":"Pagniez","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.akdh.2026.02.001_bib73","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/joneph\/17.6.778","article-title":"Thin basement membrane disease in patients with familial IgA nephropathy","volume":"17","author":"Frasca","year":"2004","journal-title":"J Nephrol"},{"issue":"7","key":"10.1053\/j.akdh.2026.02.001_bib74","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ekir.2020.04.011","article-title":"Type IV collagen mutations in familial IgA nephropathy","volume":"5","author":"Li","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"7","key":"10.1053\/j.akdh.2026.02.001_bib75","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2215\/CJN.0000000000000464","article-title":"Genomic testing in patients with kidney failure of an unknown cause: a national Australian study: a national Australian study","volume":"19","author":"Mallawaarachchi","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2026.02.001_bib76","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy","volume":"24","author":"Savige","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2026.02.001_bib77","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/ndt\/gfae180","article-title":"Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in pediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport","volume":"40","author":"Gross","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1053\/j.akdh.2026.02.001_bib78","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1016\/j.ekir.2024.09.014","article-title":"SGLT2-Inhibition in patients with Alport syndrome","volume":"9","author":"Boeckhaus","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.akdh.2026.02.001_bib79","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00467-020-04819-6","article-title":"Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020","volume":"36","author":"Kashtan","year":"2021","journal-title":"Pediatr Nephrol"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294981392600025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294981392600025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:07:48Z","timestamp":1793952468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S294981392600025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S294981392600025X"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2026.02.001","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Collagen Genes\u2013Related Glomerular Disease","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2026.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the National Kidney Foundation, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}